Sarah Gheuens Insider Profile

4 Followers
Sarah Gheuens, CMO at Agios Pharma, holds 43.74K shares in Agios Pharma (Ticker: AGIO), holds ― shares in Viridian Therapeutics (Ticker: VRDN).
tipranks
Sarah Gheuens

Sarah Gheuens
Agios Pharma (AGIO)
CMO

Not Ranked
Sarah Gheuens has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
0.00%
A breakdown of Sarah Gheuens's holdings

Insider Roles

Agios Pharma
(AGIO)
CMO
Viridian Therapeutics
(VRDN)
Director
Roles that Sarah Gheuens holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Sarah Gheuens

Sarah Gheuens's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Agios Pharma
Jul 03, 2024
CMO
Uninformative Buy
204.78K
$2.58M
Viridian Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Sarah Gheuens's performance on stock

Sarah Gheuens insider profile FAQ

What is the percentage of profitable transactions made by Sarah Gheuens?
The percentage of profitable transactions made by Sarah Gheuens is ―.
    What is the average return per transaction made by Sarah Gheuens?
    The average return per transaction made by Sarah Gheuens is ―.
      What stocks does Sarah Gheuens hold?
      Sarah Gheuens holds: AGIO, VRDN stocks.
        What was Sarah Gheuens’s latest transaction?
        Sarah Gheuens latest transaction was an Uninformative Buy of $204.78K.
          What was Sarah Gheuens's most profitable transaction?
          Sarah Gheuens’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Sarah Gheuens's role in Agios Pharma?
            Sarah Gheuens's role in Agios Pharma is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.